|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,360.00 KRW | -8.11% |
|
-10.84% | -36.07% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.11% | -10.84% | -49.01% | - | 71.07M | ||
| +0.63% | -3.94% | +86.85% | +453.23% | 36.35B | ||
| -2.25% | +9.13% | +17.36% | +43.10% | 25.19B | ||
| -0.97% | +8.17% | -18.77% | -35.99% | 7.78B | ||
| +0.24% | +7.01% | +12.08% | +95.16% | 4.98B | ||
| +0.72% | +12.35% | +22.33% | +62.96% | 3.28B | ||
| +2.92% | +1.73% | -30.61% | +791.95% | 1.89B | ||
| +3.28% | +1.14% | -11.66% | -61.93% | 1.88B | ||
| -1.35% | +1.08% | +16.63% | +4.73% | 1.78B | ||
| +13.96% | +8.99% | +190.86% | -11.53% | 1.99B | ||
| Average | +0.90% | +0.98% | +23.61% | +149.08% | 8.52B | |
| Weighted average by Cap. | -0.02% | +2.36% | +45.87% | +227.08% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















